Goldman Sachs Boss Predicts Recession, Warns Risk-Based Businesses: ‘Time To Be Cautious’
Goldman Sachs Group Inc. (NYSE: GS) CEO David Solomon is the latest high-profile executive to issue a dour economic forecast.
Starboard Value Holds A 5% Stake In Splunk: Check Out These 2 Dividend Stocks Jeffrey Smith Also Has A Sizable Stake In
The activist investor Jeffrey Smith founded Starboard Value LP in 2002, seeking to invest in deeply undervalued companies and actively engage with management teams to identify and execute on opportunities to unlock value for the
Merck Outlicenses Two Preclinical TB Candidates To Bill & Melinda Gates Research Institute
Merck & Co Inc (NYSE:MRK) and the Bill & Melinda Gates Medical Research Institute (Gates MRI) announced a licensing…
Johnson & Johnson Beats Q3 Estimates Led By Strength From Cancer, Crohn’s Disease Drugs, Tightens Guidance
Johnson & Johnson (NYSE:JNJ) has reported Q3 FY22 adjusted earnings of $2.55 per share, down 1.9% Y/Y and slightly ahead…
Tesla Shares Have A Supporter in Congress: House Rep. McKinley Also Likes These 2 Dividend Stocks
Republican Congressman David McKinley recently purchased $1,000 to $15,000 shares in Tesla (NASDAQ: TSLA) for a price of $300.80 per share, in an undisclosed position, per Capito
Are Cracks Beginning To Form? Bank Of America Is Watching Credit Card Delinquencies Closely
Bank of America Corp (NYSE: BAC) was out Monday with its current asset quality ratings.
Merger Monday Vindicated This Analyst Who Nailed BP’s Offer Price As Energy M&A Heats Up
On Oct. 4, Wells Fargo & Co. (NYSE: WFC) analyst Michael Blum initiated coverage of Archaea Energy Inc.
Netflix Q3 Earnings Preview — Analysts Pinpoint Key Metrics For Investors To Watch
Netflix Inc (NASDAQ: NFLX) reports earnings on Oct. 18 after the market close. Analysts at KeyBanc Capital Markets, and Credit Suisse offered some insight on what investors should be looking for ahead of the streaming service’s earnings.
Moderna Inks Deal For Updated COVID Shots For Low Income Countries
Moderna Inc (NASDAQ:MRNA) and Gavi, the Vaccine Alliance, agreed to cancel the remaining pending orders under the current COVID-19 vaccine supply…
Sage Therapeutics/Biogen Highlight Additional Data From Depression Candidate
Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ:BIIB) presented additional data from the Phase 3 SKYLARK Study of zuranolone in adult women with…